ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia
Acerta Pharma BV
Acerta Pharma BV
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Ohio State University Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
University of Pennsylvania
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
MedImmune LLC
Mayo Clinic
Alliance for Clinical Trials in Oncology
Northside Hospital, Inc.
National Cancer Institute (NCI)
INSYS Therapeutics Inc
Northside Hospital, Inc.
Northside Hospital, Inc.
Vanderbilt-Ingram Cancer Center
Northside Hospital, Inc.
M.D. Anderson Cancer Center
Mayo Clinic